Genmab reported DKK1.35B in Current Liabilities for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agios Pharmaceuticals AGIO:US $ 60.65M 35.85M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
Amarin AMRN:US $ 370.44M 44.67M
Amgen AMGN:US $ 14585M 1716M
AstraZeneca AZN:LN 22222M 709M
Bayer BAYN:GR € 27926M 1006M
Biomarin Pharmaceutical BMRN:US $ 443.34M 13.31M
Bluebird Bio BLUE:US $ 247.76M 41.45M
Exelixis EXEL:US $ 255.33M 41.99M
Fresenius Medical Care FME:GR € 7425M 182M
Galapagos GLPG:NA € 576.98M 28.38M
Genmab GEN:DC DK 1351M 58M
GlaxoSmithKline GSK:LN 21387M 1112M
GN Store Nord GN:DC DK 4575M 64M
GRIFOLS GRF:SM € 1921.48M 360.62M
H. Lundbeck A/S LUN:DC 8.44B 474M
Hikma Pharmaceutical HIK:LN 960M 68M
Immunogen IMGN:US $ 120.32M 14.03M
Insmed INSM:US $ 99.66M 18.26M
Lonza Group LONN:SW 3.11B 12M
Merck MRK:GR € 9820M 832M
Novartis NOVN:VX SF 29633M 527M
Regeneron Pharmaceuticals REGN:US $ 3732.4M 514.6M
Seattle Genetics SGEN:US $ 433.83M 44.22M
William Demant Holding WDH:DC 9.47B 2.1B